IM Cannabis Financials - Benzinga

IM Cannabis Corp

IMCCNASDAQ

Trade with Public

Trade with Public

$3.00

-0.18-5.66%

Últ. Act.: Sep 25, 9:29 AM

Panorámica general Noticias Previsión de beneficiosFinanzasSentimiento Comparar Informe de acciones

IM Cannabis Financials

IM Cannabis (IMCC) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
IM Cannabis Q2 EPS $(0.34) Down From $(0.07) YoY, Sales $5.482M Down From $9.172M YoY

IM Cannabis (NASDAQ:IMCC) reported quarterly losses of $(0.34) per share. This is a 385.71 percent decrease over losses of $(0.07) per share from the same period last year. The company reported $5.482 million in sales

Benzinga Newsdesk

PRO
IM Cannabis Q1 EPS $(0.28) Down From $0.06 YoY, Sales $6.343M Down From $8.708M YoY

IM Cannabis (NASDAQ:IMCC) reported quarterly losses of $(0.28) per share. This is a 566.67 percent decrease over earnings of $0.06 per share from the same period last year. The company reported $6.343 million in sales

Benzinga Newsdesk

PRO
IM Cannabis Q4 EPS $(0.86) Down From $(0.23) YoY, Sales $11.249M Up From $9.535M YoY

IM Cannabis (NASDAQ:IMCC) reported quarterly losses of $(0.86) per share. This is a 273.91 percent decrease over losses of $(0.23) per share from the same period last year. The company reported $11.249 million in sales

Benzinga Newsdesk

PRO
IM Cannabis Q3 EPS $(0.54) Down From $(0.30) YoY, Sales $10.060M Down From $10.177M YoY

IM Cannabis (NASDAQ:IMCC) reported quarterly losses of $(0.54) per share. This is a 80 percent decrease over losses of $(0.30) per share from the same period last year. The company reported $10.060 million in sales this

Benzinga Newsdesk

Earnings Scheduled For November 13, 2025

Benzinga Insights

PRO
IM Cannabis Q2 EPS $(0.07) Up From $(0.17) YoY, Sales $9.172M Down From $10.782M YoY

IM Cannabis (NASDAQ:IMCC) reported quarterly losses of $(0.07) per share. This is a 58.82 percent increase over losses of $(0.17) per share from the same period last year. The company reported $9.172 million in sales

Benzinga Newsdesk

© 2026 Benzinga | All Rights Reserved